Evidence brief · Supplement

Alpha-Lipoic Acid for Diabetic neuropathy

Evidence grade B — Symptom relief

Overall grade
Grade B
Last revised
1
graded outcome
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade B — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Diabetic neuropathyEvidence grade B

    Symptom relief

    Unclearmixed

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Studies disagree: Diabetic neuropathy (mixed agreement).

The evidence in words

The verdict

For diabetic neuropathy, Alpha-Lipoic Acid earns evidence grade B (unclear effect, mixed consistency) — there is real evidence here. Symptom relief

How it might work

It regenerates other antioxidants and improves insulin signaling and nerve microcirculation, the basis for its neuropathy use.

How to use it

300–600 mg/day (R-ALA is the active isomer); take on an empty stomach for absorption.

Safety & cautions

Generally safe; can lower glucose (watch for lows with diabetes meds) and rarely triggers an insulin-autoimmune reaction.

Bottom line

A legitimate option for diabetic neuropathy symptoms and mild glucose improvement. 300–600 mg/day; coordinate with any diabetes medication.

How it is used

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

Standard
300–600 mg/day, empty stomach.

Goes with

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.